Last reviewed · How we verify
Myxedema
Approved treatments
- Unithroid · Fresenius Kabi
Unithroid works by replacing or supplementing the thyroid hormone thyroxine, which is produced by the thyroid gland. - Triostat · Pfizer
Triostat works by mimicking the natural thyroid hormone, l-Triiodothyronine, to stimulate the thyroid hormone receptor alpha. - levothyroxin · Ain Shams University
- Thyroxine · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Synthroid · Generic (originally multiple — AbbVie/Synthroid)
Synthetic thyroxine (T4) that replaces deficient thyroid hormone, restoring normal metabolism, growth, and development. - Triiodothyronine · Northwell Health
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Myxedema patent landscape — cliff calendar, originator estates, attackable patents
- Myxedema treatment landscape brief
- Myxedema treatment updates RSS
Frequently asked questions about Myxedema
What drugs treat Myxedema?
Tracked treatments include Unithroid, Triostat, levothyroxin, Thyroxine, Synthroid, Triiodothyronine.
What is the treatment for Myxedema?
Standard treatment for Myxedema includes Unithroid, Triostat, levothyroxin, Thyroxine, Synthroid. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Myxedema patent cliff · Myxedema CI report
- Treatment: Unithroid · Fresenius Kabi
- Treatment: Triostat · Pfizer
- Treatment: levothyroxin · Ain Shams University
- Treatment: Thyroxine · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Treatment: Synthroid · Generic (originally multiple — AbbVie/Synthroid)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing